ESLA CIK: 1844417

Estrella Immunopharma, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY22
FY22
FY23
FY24
FY25
FY22 – FY25
(positive)
millions USD
FY22:
–
FY22:
–
FY23:
–
FY24:
–
FY25:
–
(positive)
Change from FY22 to FY25
millions USD
FY22:
−1.69
FY22:
−1.57
FY23:
−11.1
FY24:
−7.31
FY25:
−13.1
(positive)
Change from FY22 to FY25
millions USD
FY22:
−1.69
FY22:
–
FY23:
−11.1
FY24:
−7.31
FY25:
−13.1
(positive)
Change from FY22 to FY25
millions USD
FY22:
−1.69
FY22:
−0.92
FY23:
−11.1
FY24:
−7.31
FY25:
−13.1
(positive)
Change from FY22 to FY25
millions USD
FY22:
−1.69
FY22:
−1.00
FY23:
−11.1
FY24:
−7.31
FY25:
−13.1

All amounts in millions USD Data sources:SEC EDGARTwelve Data